Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Basal Cell Carcinoma”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04806646
What this trial is testing

Tailored Sonidegib Schedule After Complete Response in BCC

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Gruppo Oncologico del Nord-Ovest 21
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Looking for participantsNCT06344052
What this trial is testing

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Stamford Pharmaceuticals, Inc. 80
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Not applicableLooking for participantsNCT05463757
What this trial is testing

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

Who this might be right for
Basal Cell CarcinomaLocally Advanced Basal Cell CarcinomaMetastatic Basal Cell Carcinoma+8 more
Maastricht University Medical Center 80
Not applicableStudy completedNCT01529450
What this trial is testing

Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors

Who this might be right for
Basal Cell Carcinoma
Anne Chang 11
Early research (Phase 1)Study completedNCT03458117
What this trial is testing

T-VEC in Non-melanoma Skin Cancer

Who this might be right for
Non-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma+2 more
University of Zurich 26
Testing effectiveness (Phase 2)Study completedNCT01700049
What this trial is testing

Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes

Who this might be right for
Basal Cell Carcinoma
Mayo Clinic 28
Not applicableStudy completedNCT02674009
What this trial is testing

Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)

Who this might be right for
Carcinoma, Basal Cell
Hoffmann-La Roche 67
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07227870
What this trial is testing

L19IL2/TNF in Patients With Basal Cell Carcinoma

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Philogen S.p.A. 92
Not applicableApproved For MarketingNCT01160250
What this trial is testing

Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Genentech, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT03521830
What this trial is testing

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 57
Not applicableLooking for participantsNCT07215988
What this trial is testing

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

Who this might be right for
Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
Ohio State University Comprehensive Cancer Center 70
Not applicableStudy completedNCT00851253
What this trial is testing

Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Boston Medical Center 12
Not applicableStudy completedNCT02781389
What this trial is testing

Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions

Who this might be right for
Basal Cell Carcinoma
University Hospital, Essen 53
Post-approval studies (Phase 4)Study completedNCT06880848
What this trial is testing

Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China

Who this might be right for
Carcinoma, Basal Cell (BCC)
Jemincare 160
Testing effectiveness (Phase 2)Study completedNCT01835626
What this trial is testing

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Who this might be right for
Locally Advanced Basal Cell CarcinomaSkin CancerCutaneous Malignancy
Sue Yom 24
Testing effectiveness (Phase 2)Study completedNCT01367665
What this trial is testing

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Hoffmann-La Roche 1,232
Testing effectiveness (Phase 2)Active Not RecruitingNCT04349436
What this trial is testing

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

Who this might be right for
Merkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more
Replimune, Inc. 69
Not applicableStudy completedNCT03836105
What this trial is testing

CemiplimAb Survivorship Epidemiology

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
Regeneron Pharmaceuticals 287
Load More Results